Kalkine has a fully transformed New Avatar.

Batm Advanced Communications Ltd

Healthcare GB BVC

15.1GBX
0.45(3.07%)

Last update at 2026-03-10T15:43:00Z

Day Range

14.7015.30
LowHigh

52 Week Range

12.2020.00
LowHigh

Fundamentals

  • Previous Close 14.65
  • Market Cap53.56M
  • Volume72208
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.93300M
  • Revenue TTM118.82M
  • Revenue Per Share TTM0.27
  • Gross Profit TTM 37.87M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -5.72800M 1.95M 1.90M 24.93M 13.30M
Minority interest -0.04200M 0.00700M -0.62600M -0.41700M -3.83000M
Net income -22.29600M -0.19300M 1.56M 14.34M 9.79M
Selling general administrative 3.81M 15.13M 13.02M 12.24M 15.88M
Selling and marketing expenses 3.78M 19.13M 17.21M 18.29M 20.20M
Gross profit 36.80M 38.30M 37.96M 51.06M 60.71M
Reconciled depreciation 4.97M 5.18M 4.89M 5.26M 5.47M
Ebit -3.99600M 2.83M 3.13M 24.38M 14.23M
Ebitda 0.97M 8.01M 8.80M 31.11M 20.53M
Depreciation and amortization 4.97M 5.18M 5.66M 6.73M 6.29M
Non operating income net other - - - - -
Operating income -4.66100M 2.73M 3.13M 24.38M 14.23M
Other operating expenses 122.00M 114.00M 112.99M 115.66M 169.33M
Interest expense 1.39M 1.29M 2.01M 0.91M 1.75M
Tax provision 1.73M 0.84M 0.34M 9.34M 1.04M
Interest income 0.42M 1.03M 0.73M 1.47M 0.82M
Net interest income -0.96600M -0.34600M -0.60400M 0.56M -0.93400M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1.73M 0.78M 0.34M 9.34M 1.04M
Total revenue 117.34M 116.73M 116.12M 140.04M 183.57M
Total operating expenses 41.46M 35.57M 34.82M 26.68M 46.48M
Cost of revenue 80.54M 82.94M 78.17M 88.98M 122.86M
Total other income expense net -1.06700M -0.78100M -1.23900M 0.56M -0.93400M
Discontinued operations - - - - -
Net income from continuing ops -7.45600M -0.20000M 0.87M 14.76M 11.48M
Net income applicable to common shares - - 0.24M 14.34M 9.79M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 149.16M 174.63M 175.18M 193.16M 200.11M
Intangible assets 8.00M 8.02M 5.95M 4.65M 6.88M
Earning assets - - - - -
Other current assets 8.10M 6.88M - 34.93M 41.47M
Total liab 56.18M 55.19M 61.18M 69.03M 81.34M
Total stockholder equity 94.06M 120.34M 115.07M 127.42M 122.59M
Deferred long term liab - - - - -
Other current liab 16.64M 16.55M 0.82M 6.55M 3.05M
Common stock 1.32M 1.32M 1.32M 1.32M 1.32M
Capital stock 1.32M 1.32M 1.32M 1.32M 1.32M
Retained earnings -302.16200M -279.76700M -279.57900M -279.88800M -290.09000M
Other liab - - 4.13M 4.68M 7.96M
Good will 3.34M 12.76M 12.58M 11.38M 16.84M
Other assets - - 3.98M 5.11M 7.64M
Cash 25.90M 32.34M 35.16M 65.33M 50.58M
Cash and equivalents - - - - -
Total current liabilities 46.58M 47.13M 51.29M 57.89M 64.27M
Current deferred revenue - - - - -
Net debt -17.24700M -23.25500M -25.17900M -55.04700M -33.85100M
Short term debt 6.29M 5.11M 4.22M 3.82M 7.61M
Short long term debt 4.26M 3.28M 2.23M 1.63M 5.37M
Short long term debt total 8.65M 9.08M 9.98M 10.28M 16.72M
Other stockholder equity 429.60M 398.79M 393.33M 405.99M 411.36M
Property plant equipment - - 20.77M 24.68M 25.72M
Total current assets 98.55M 110.21M 115.12M 133.65M 128.74M
Long term investments - - - - -
Net tangible assets - - 96.54M 111.39M 98.88M
Short term investments 5.67M 8.43M 9.01M 2.43M 2.80M
Net receivables 26.18M 24.33M 25.61M 34.93M 35.00M
Long term debt 0.00000M 1.33M 2.00M 1.36M 0.68M
Inventory 32.71M 38.23M 34.46M 30.95M 33.89M
Accounts payable 20.90M 22.53M 46.26M 47.52M 53.62M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -34.69300M -29.86500M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - 1.32M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 6.22M 12.54M 9.63M 4.17M 4.68M
Deferred long term asset charges - - - - -
Non current assets total 50.61M 64.42M 60.06M 59.52M 71.37M
Capital lease obligations 4.39M 4.48M 5.74M 7.29M 10.68M
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -1.21600M -6.12000M -16.34200M -0.32500M -1.90700M
Change to liabilities - - 0.00000M -5.35200M 7.11M
Total cashflows from investing activities -1.21600M -6.12000M -16.34200M 15.07M -5.48100M
Net borrowings -0.09900M 0.00200M -0.74400M -4.99500M -3.30000M
Total cash from financing activities -2.61200M -2.16000M -7.05000M -4.93700M -3.24900M
Change to operating activities - - - -3.42900M 2.21M
Net income -4.66100M -0.19300M 3.13M 24.38M 14.23M
Change in cash -6.44100M -2.81700M -30.17500M 14.76M 9.99M
Begin period cash flow 32.34M 35.16M 65.33M 50.58M 40.58M
End period cash flow 25.90M 32.34M 35.16M 65.33M 50.58M
Total cash from operating activities -1.65300M 5.01M -2.78400M 5.59M 18.46M
Issuance of capital stock - - 0.00000M 0.06M 0.05M
Depreciation 4.97M 5.18M 4.89M 5.26M 5.47M
Other cashflows from investing activities -1.92000M -1.83700M - 0.00300M 0.10M
Dividends paid - - 4.30M 4.30M 4.30M
Change to inventory -0.52100M -3.99800M -3.25800M 3.03M -11.19800M
Change to account receivables -1.19700M 4.61M - -2.05200M 0.92M
Sale purchase of stock - 0.00000M -1.32500M - 0.05M
Other cashflows from financing activities -2.51300M -2.16200M 9.59M 8.26M 10.55M
Change to netincome - - -1.01100M -6.21000M 4.15M
Capital expenditures 3.41M 2.37M 4.47M 3.29M 3.71M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -4.33200M -3.58200M -6.90800M -4.37300M -0.96100M
Stock based compensation 0.94M 2.52M 0.30M 0.10M 0.16M
Other non cash items 1.43M 1.09M -4.19900M -19.77300M -0.44600M
Free cash flow -5.06000M 2.64M -7.25200M 2.30M 14.74M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BVC
Batm Advanced Communications Ltd
0.45 3.07% 15.10 - - 0.45 0.71 0.45 11.26
CTEC
ConvaTec Group PLC
6.60 2.77% 245.00 40.37 16.18 1.94 4.09 3.14 14.84
AMS
Advanced Medical Solutions Group plc
6.70 3.44% 201.50 50.25 17.86 1.97 1.78 2.36 13.12
TSTL
Tristel
8.00 2.11% 388.00 51.11 37.04 6.08 7.11 5.94 27.03
SPEC
Inspecs Group plc
-0.075 0.09% 82.92 - 12.29 0.42 0.80 0.60 9.42

Reports Covered

Stock Research & News

Profile

BATM Advanced Communications Ltd., together with its subsidiaries, engages in the development, production, and supply of real-time technologies and associated services in Israel, the United States, and Europe. It operates through four segments: Cyber, Networking, Diagnostics, and Non-core. The Cyber segment provides integrated hardware and software solutions for network encryption, including hardware security modules. The Networking segment engages in researching and developing, and marketing of data communication products, including Edgility, an open edge software platform that enables the deployment and life-cycle management of apps, network functions, and compute devices at the edge of the network; and a range of carrier grade products for switching and routing hardware and software products. The Diagnostics segment is involved in the development, sale, and distribution of in vitro diagnostics reagents and instruments, including proprietary products that focus on molecular diagnostics by test type and infectious disease by application area. The Non-core segment distributes pharmaceutical and environmental monitoring products, as well as engages in the production of ecofriendly pathogenic waste treatment solutions for medical, agricultural, and pharmaceutical applications. The company provides software services, such as training and technical support; laboratory service and maintenance; and construction contract services. BATM Advanced Communications Ltd. was incorporated in 1992 and is headquartered in Hod Hasharon, Israel.

Batm Advanced Communications Ltd

Neve Ne?eman Ind. Area, Hod Hasharon, Israel, 4524075

Key Executives

Name Title Year Born
Dr. Zvi Marom Founder, CEO & Exec. Director 1955
Mr. Moti Nagar CFO & Exec. Director NA
Mr. Ariel Efrati COO of Telecom Division & CEO of Telco Systems NA
Mr. Yair Livneh Company Sec. NA
Mr. Moti Nagar CPA CEO & Executive Director NA
Mr. Leor Miles CPA CFO & Executive Director NA
Mr. Haim Schwartz Chief Operating Officer NA
Mr. Yair Livneh Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.